Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Global X Management CO LLC UROY Uranium Royalty Corp. 13G/A 5.74% 6mo
Redmile Group, LLC SRRK Scholar Rock Holding Corp 13G/A 7.6% 6mo
METEORA CAPITAL, LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G/A 19.18% 6mo
CVI Investments, Inc. SCYX Scynexis Inc 13G/A 6.2% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ PLNT Planet Fitness, Inc. 13G/A 3.7% 6mo
DISCIPLINED GROWTH INVESTORS INC /MN KRNT Kornit Digital Ltd. 13G/A 6.5% 6mo
TD SECURITIES (USA) LLC MDRX Veradigm Inc. Common Stock 13G/A 6.9% 6mo
T. Rowe Price Investment Management, Inc. IR Ingersoll Rand Inc. 13G/A 4.5% 6mo
Vestal Point Capital, LP ELVN Enliven Therapeutics, Inc. 13G/A 5.4% 6mo
Woodline Partners LP ALGS Aligos Therapeutics, Inc. 13G/A 4.4% 6mo
JANUS HENDERSON GROUP PLC COLL Collegium Pharmaceutical, Inc 13G 5.8% 6mo
1607 Capital Partners, LLC IGI Western Asset Investment Grade Opportunity Trust Inc. 13G/A 6.79% 6mo
Alyeska Investment Group, L.P. CSHR CoinShares PLC 13G 5.97% 6mo
CITADEL ADVISORS LLC ALLO Allogene Therapeutics, Inc. 13G/A 2.8% 6mo
Squadron Capital Management LLC TRAW Traws Pharma, Inc. 13G/A 6.4% 6mo
TURTLE CREEK ASSET MANAGEMENT INC. ATS ATS Corp 13G/A 4.99% 6mo
Avoro Capital Advisors LLC CNTA Centessa Pharmaceuticals plc 13G/A 7.39% 6mo
WELLINGTON MANAGEMENT GROUP LLP AIG American International Group, Inc. 13G 5.3% 6mo
Divisadero Street Capital Management, LP BBW Build-A-Bear Workshop Inc 13G/A 7.9% 6mo
BROWN ADVISORY INC ANDG Andersen Group Inc. 13G/A 19.89% 6mo
TENOR CAPITAL MANAGEMENT Co., L.P. FACT FACT II Acquisition Corp. 13G/A 8.1% 6mo
Deep Track Capital, LP APLS Apellis Pharmaceuticals, Inc. 13G/A 3.55% 6mo
Greenhouse Funds LLLP MCW Mister Car Wash, Inc. 13G/A 4.1% 6mo
Joe Hayon QTEX QTREX Quantum Ltd. 13G/A 5.7% 6mo
TD SECURITIES (USA) LLC HTZ Hertz Global Holdings, Inc 13G/A 8.1% 6mo
JANUS HENDERSON GROUP PLC NERV Minerva Neurosciences, Inc. 13G 9.9% 6mo
Bain Capital Life Sciences Opportunities IV, L.P. OLMA Olema Oncology, Inc. 13G/A 8.15% 6mo
Cormorant Asset Management, LP RAPP Rapport Therapeutics, Inc. 13G/A 6.19% 6mo
AMERIPRISE FINANCIAL INC MEI Methode Electronics Inc 13G 5.6% 6mo
First Trust Capital Management L.P. BLFY Blue Foundry Bancorp 13G 5.25% 6mo
Global X Management CO LLC UUUU Energy Fuels Inc 13G/A 6.83% 6mo
WELLINGTON MANAGEMENT GROUP LLP HUBG Hub Group, Inc. 13G/A 11.5% 6mo
CVI Investments, Inc. RVPH Reviva Pharmaceuticals Holdings, Inc. 13G/A 4.9% 6mo
Caligan Partners LP LBRX Lb Pharmaceuticals Inc 13G 5% 6mo
Saba Capital Management, L.P. WENN WEN Acquisition Corp 13G/A 6.6% 6mo
Orbis Investment Management Limited PTLO Portillo's Inc. 13G/A 9.8% 6mo
VIKING GLOBAL INVESTORS LP CHWY Chewy, Inc. 13G/A 0% 6mo
Alyeska Investment Group, L.P. USAR USA Rare Earth, Inc. 13G/A 7.6% 6mo
ARMISTICE CAPITAL, LLC CHGA Change Agents Corporation. 13G 9.99% 6mo
Deep Track Capital, LP NRIX Nurix Therapeutics, Inc. 13G/A 6.17% 6mo
WELLINGTON MANAGEMENT GROUP LLP TREX Trex Co Inc 13G/A 8% 6mo
TD SECURITIES (USA) LLC CAEP Cantor Equity Partners III, Inc. 13G/A 5% 6mo
WELLINGTON MANAGEMENT GROUP LLP PNFP Pinnacle Financial Partners, Inc. 13G 6% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ UPWK Upwork, Inc 13G/A 13.4% 6mo
BCLS Fund III Investments, LP HTFL Heartflow, Inc. 13G/A 12.18% 6mo
Woodline Partners LP TNGX Tango Therapeutics, Inc. 13G/A 5.6% 6mo
Broad Bay Capital Management, LP BATRA Atlanta Braves Holdings, Inc. 13G 5.2% 6mo
Berkshire Hathaway Inc POOL Pool Corp 13G/A 0% 6mo
Winklevoss Capital Fund, LLC EMPD Empery Digital Inc. 13G 7.9% 6mo
Point72 Asset Management, L.P. SNDX Syndax Pharmaceuticals Inc 13G/A 2.3% 6mo